X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (108) 108
index medicus (99) 99
male (91) 91
female (86) 86
middle aged (86) 86
adult (79) 79
hematology (78) 78
aged (72) 72
oncology (49) 49
aged, 80 and over (44) 44
treatment outcome (44) 44
adolescent (41) 41
young adult (38) 38
prognosis (31) 31
cancer (30) 30
original (27) 27
original article (26) 26
retrospective studies (26) 26
medicine & public health (24) 24
chemotherapy (23) 23
multiple myeloma (23) 23
risk factors (23) 23
disease-free survival (22) 22
hemic and lymphatic diseases (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
leukemia (18) 18
survival (18) 18
의학일반 (17) 17
medicine, general & internal (16) 16
transplantation (16) 16
care and treatment (15) 15
leukemia, myeloid, acute - genetics (14) 14
multiple myeloma - drug therapy (14) 14
risk (14) 14
mutation (13) 13
analysis (12) 12
bortezomib (12) 12
dendritic cells (12) 12
diagnosis (12) 12
hematology, oncology and palliative medicine (12) 12
kaplan-meier estimate (12) 12
mortality (12) 12
remission induction (12) 12
republic of korea (12) 12
survival analysis (12) 12
acute myeloid leukemia (11) 11
antineoplastic agents - therapeutic use (11) 11
aml (10) 10
follow-up studies (10) 10
hematopoietic stem cell transplantation (10) 10
immunotherapy (10) 10
medical colleges (10) 10
multiple myeloma - pathology (10) 10
myelodysplastic syndromes (10) 10
normal karyotype (10) 10
survival rate (10) 10
therapy (10) 10
leukemia, myeloid, acute - therapy (9) 9
t cells (9) 9
thalidomide (9) 9
chromosomes (8) 8
chronic myeloid leukemia (8) 8
dexamethasone (8) 8
genetic aspects (8) 8
genotype (8) 8
leukemia, myeloid, acute - mortality (8) 8
multiple myeloma - mortality (8) 8
multivariate analysis (8) 8
myelodysplastic syndrome (8) 8
polymorphism, single nucleotide (8) 8
recurrence (8) 8
research (8) 8
stem cells (8) 8
병리학 (8) 8
antimitotic agents (7) 7
antineoplastic agents (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
azacitidine (7) 7
boronic acids - administration & dosage (7) 7
case-control studies (7) 7
chronic myelogenous leukemia (7) 7
cyclophosphamide - administration & dosage (7) 7
dendritic cells - immunology (7) 7
dexamethasone - administration & dosage (7) 7
disease progression (7) 7
genetic predisposition to disease (7) 7
hematopoietic stem cells (7) 7
imatinib (7) 7
lymphoma (7) 7
oncology & hematology (7) 7
prospective studies (7) 7
pyrazines - administration & dosage (7) 7
republic of korea - epidemiology (7) 7
research article (7) 7
rituximab (7) 7
stem-cell transplantation (7) 7
thalidomide - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
child (6) 6
cyclophosphamide (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5631 - 5631
Abstract Background: Glucocorticoids has been a backbone of various treatment regimens for multiple myeloma (MM). The repeated and chronic use of high doses of... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1822 - 1822
Abstract Background It has been well known that peripheral T cell lymphoma (PTCL) has undergone poor prognosis compared with other non-Hodgkin lymphomas (NHL).... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 3276 - 3276
Abstract The purpose of this study was to identify incidence and predictive factors of peripheral blood stem cell (PBSC) mobilization failure in patients with... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5166 - 5166
Abstract Background With imatinib therapy, the survival of patients with CML has improved dramatically. In recent years, second generation TKI (2G TKI) led to... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5313 - 5313
Abstract The International Staging System (ISS) is a robust prognostic tool for patients with symptomatic multiple myeloma (MM). In this study, we evaluated... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2596 - 2596
Abstract BACKGROUND: Acute myeloid leukemia (AML) is a biologically heterogeneous disease that can be classified into three distinct categories. For example,... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2876 - 2876
Abstract Introduction Acute myeloid leukemia (AML) is a genetically heterogeneous disease. A recent study (NEJM, 2016) classified 1540 patients into 14... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5253 - 5253
Abstract Background and Objectives Acute Myeloid Leukemia (AML) is a cytogenetically and molecularly heterogeneous disease. In the recent decades, many genetic... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 52 - 52
Abstract Introduction: Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders characterized by dysplastic changes in one or more cellular lineages... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5432 - 5432
Abstract Introduction Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall survival (OS) and response to... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4307 - 4307
Abstract Introduction Acute myeloid leukemia (AML) that develops from pre-existing hematologic diseases, rather than developing de novo, is known as secondary... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4281 - 4281
Abstract Introduction: The discoveries of JAK2-V617F as well as MPL and CARL mutations have greatly clarified the underlying genetics of Philadelphia negative... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 5089 - 5089
Abstract Abstract 5089 Systemic inflammatory responses as evidenced by CRP and albumin have reported as a useful indicator of prognosis in patients with... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2013, Volume 161, Issue 3, pp. 339 - 347
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 4758 - 4758
Introduction Eltrombopag is a synthetic non-peptide thrombopoietin receptor agonist (TPO-RA), which shows an excellent treatment outcome in immune... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. 656 - 664
Decitabine has shown clinical benefits in patients with intermediate (INT)-2 or high-risk myelodysplastic syndrome (MDS), determined according to the... 
LR-PSS | Decitabine | Lower-Risk Prognostic Scoring System | IPSS | Myelodysplastic syndrome
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3890 - 3890
Abstract Our previous study showed that a less toxic regimen comprising reduced cyclophosphamide (Cy), fludarabine and anti-thymocyte globulin (ATG)... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.